Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease

SARS coronavirus main protease (SARS-CoV M(pro)) is essential for the replication of the virus and regarded as a major antiviral drug target. The enzyme is a cysteine protease, with a catalytic dyad (Cys-145/His-41) in the active site. Aldehyde inhibitors can bind reversibly to the active-site sulfh...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lili, George, Shyla, Schmidt, Marco F., Al-Gharabli, Samer I., Rademann, Jörg, Hilgenfeld, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114241/
https://www.ncbi.nlm.nih.gov/pubmed/21854807
http://dx.doi.org/10.1016/j.antiviral.2011.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114241/
https://www.ncbi.nlm.nih.gov/pubmed/21854807
http://dx.doi.org/10.1016/j.antiviral.2011.08.001

Ejemplares similares